Pulmonary Medicine - Global Oncology Academy

1-16 of 68

The Epigenetics of Lung Cancer Dormancy and Relapse
The Epigenetics of Lung Cancer Dormancy and Relapse
Project Oncology®
The Epigenetics of Lung Cancer Dormancy and Relapse
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Project Oncology®
Early Detection Shapes Outcomes in Post-Transplant Lung Cancer
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Project Oncology®
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
AudioAbstracts
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
- Ryan Quigley
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
Project Oncology®
Why Molecular Testing Matters in Non-Small Cell Lung Cancer
- Geoffrey Oxnard, MD
Integrating Molecular Testing into NSCLC Care
Integrating Molecular Testing into NSCLC Care
Project Oncology®
Integrating Molecular Testing into NSCLC Care
- Geoffrey Oxnard, MD
A New Era of Hope in Non-Small Cell Lung Cancer Care
A New Era of Hope in Non-Small Cell Lung Cancer Care
Project Oncology®
A New Era of Hope in Non-Small Cell Lung Cancer Care
- Geoffrey Oxnard, MD
Smarter Screening for Non-Small Cell Lung Cancer
Smarter Screening for Non-Small Cell Lung Cancer
Project Oncology®
Smarter Screening for Non-Small Cell Lung Cancer
- Jobelle Baldonado, MD
Recognizing High-Risk Profiles for NSCLC
Recognizing High-Risk Profiles for NSCLC
Project Oncology®
Recognizing High-Risk Profiles for NSCLC
- Jobelle Baldonado, MD
Oncogenic Drivers in Never-Smokers with NSCLC
Oncogenic Drivers in Never-Smokers with NSCLC
Project Oncology®
Oncogenic Drivers in Never-Smokers with NSCLC
- Apar Kishor Ganti, MD, MS
Expanding Molecular Testing in Community NSCLC Care
Expanding Molecular Testing in Community NSCLC Care
Project Oncology®
Expanding Molecular Testing in Community NSCLC Care
- Apar Kishor Ganti, MD, MS
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Project Oncology®
Modern Management of ROS1-Positive Non-Small Cell Lung Cancer
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
AudioAbstracts
Understanding Safety Profiles of ROS1 TKIs in Advanced Non-Small Cell Lung Cancer
- Ryan Quigley
Dato-DXd’s Intracranial Efficacy in NSCLC: Insights from TROPION-Lung01
Dato-DXd’s Intracranial Efficacy in NSCLC: Insights from TROPION-Lung01
Project Oncology®
Dato-DXd’s Intracranial Efficacy in NSCLC: Insights from TROPION-Lung01
- Jacob Sands, MD
- Aaron Lisberg, MD
Dato-DXd in Non-Small Cell Lung Cancer: Implications of TROPION-Lung01 Data
Dato-DXd in Non-Small Cell Lung Cancer: Implications of TROPION-Lung01 Data
Project Oncology®
Dato-DXd in Non-Small Cell Lung Cancer: Implications of TROPION-Lung01 Data
- Jacob Sands, MD
- Julia Rotow, MD
- Xiuning Le, MD, PhD

Prev
1
2
3
4
5
Next

1/5